IQVIA Americas — Revenue decreased by 4.2% to $1.98B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.8%, from $1.81B to $1.98B. Over 4 years (FY 2021 to FY 2025), Americas — Revenue shows an upward trend with a 3.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates growing market share or higher demand for services in the Americas, while a decrease may signal regional economic headwinds or increased competitive pressure.
This metric represents the total gross income generated from sales of services and products within the Americas geograph...
Comparable to regional revenue reporting for global life sciences or healthcare services firms, often benchmarked against regional GDP growth or pharmaceutical R&D spending trends.
iqv_segment_americas_revenues| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.66B | $1.68B | $1.80B | $1.72B | $1.67B | $1.80B | $1.86B | $1.80B | $1.82B | $1.86B | $2.07B | $1.80B | $1.86B | $1.84B | $1.85B | $1.81B | $1.94B | $1.93B | $2.07B | $1.98B |
| QoQ Change | — | +1.6% | +6.8% | -4.4% | -2.8% | +7.6% | +3.7% | -3.3% | +1.1% | +1.9% | +11.7% | -13.1% | +3.4% | -1.3% | +0.8% | -2.5% | +7.1% | -0.1% | +7.1% | -4.2% |
| YoY Change | — | — | — | — | +0.8% | +6.8% | +3.7% | +4.8% | +9.0% | +3.3% | +11.3% | +0.1% | +2.3% | -1.0% | -10.7% | +0.3% | +3.9% | +5.2% | +11.7% | +9.8% |